Metarrestin derivatives as selective anti-cancer agents with reduced CNS exposure

Project: Research project

Project Details

StatusFinished
Effective start/end date9/28/2012/31/23

Funding

  • University of North Carolina at Chapel Hill (Agmt 9/28/2020 AMD 2)